Short Interest in Stevanato Group S.p.A. (NYSE:STVN) Declines By 19.9%

Stevanato Group S.p.A. (NYSE:STVN) saw a significant decrease in short interest in the month of February. As of February 27th, there was short interest totaling 1,539,632 shares, a decrease of 19.9% from the February 12th total of 1,922,035 shares. Based on an average daily trading volume, of 625,122 shares, the short-interest ratio is presently 2.5 days. Approximately 0.5% of the company’s stock are short sold. Approximately 0.5% of the company’s stock are short sold. Based on an average daily trading volume, of 625,122 shares, the short-interest ratio is presently 2.5 days.

Analyst Ratings Changes

Several equities research analysts recently commented on STVN shares. KeyCorp dropped their target price on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, March 5th. Morgan Stanley decreased their price target on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, March 6th. Citigroup lowered their price objective on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. Jefferies Financial Group set a $17.50 price objective on shares of Stevanato Group in a research note on Tuesday, February 10th. Finally, Wall Street Zen cut shares of Stevanato Group from a “buy” rating to a “hold” rating in a research report on Saturday, February 14th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy”.

Stevanato Group Stock Performance

Shares of NYSE:STVN traded up €0.10 on Tuesday, reaching €15.45. 286,259 shares of the company’s stock were exchanged, compared to its average volume of 703,794. The business’s 50-day moving average is €16.94 and its two-hundred day moving average is €21.34. The company has a quick ratio of 1.26, a current ratio of 1.76 and a debt-to-equity ratio of 0.23. Stevanato Group has a fifty-two week low of €13.91 and a fifty-two week high of €28.00. The firm has a market capitalization of $4.68 billion, a price-to-earnings ratio of 26.63, a PEG ratio of 1.37 and a beta of 0.57.

Hedge Funds Weigh In On Stevanato Group

A number of large investors have recently bought and sold shares of the business. Pembroke Management LTD raised its position in shares of Stevanato Group by 11.9% during the 3rd quarter. Pembroke Management LTD now owns 1,283,216 shares of the company’s stock worth $33,043,000 after purchasing an additional 136,710 shares during the period. Cooper Investors PTY Ltd. boosted its position in Stevanato Group by 251.7% during the 3rd quarter. Cooper Investors PTY Ltd. now owns 590,308 shares of the company’s stock valued at $15,200,000 after purchasing an additional 422,478 shares during the period. ArrowMark Colorado Holdings LLC boosted its position in Stevanato Group by 6.7% during the 3rd quarter. ArrowMark Colorado Holdings LLC now owns 1,392,581 shares of the company’s stock valued at $35,859,000 after purchasing an additional 86,971 shares during the period. Thrivent Financial for Lutherans grew its stake in Stevanato Group by 7.1% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,372,390 shares of the company’s stock worth $61,089,000 after buying an additional 156,733 shares during the last quarter. Finally, Ranger Investment Management L.P. grew its stake in Stevanato Group by 125.6% during the 2nd quarter. Ranger Investment Management L.P. now owns 1,321,030 shares of the company’s stock worth $32,273,000 after buying an additional 735,417 shares during the last quarter.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.